Editor’s note: William Canestaro is managing director at Seattle venture capital firm WRF Capital and leads the biotechnology investment team. Seagen’s sale to Pfizer would have seemed unthinkable a few… Read More
Prenuvo, the celebrity-endorsed company offering $2,500 full-body MRI scans designed to detect cancer and other diseases early, is planning to open one of its clinics in Seattle in 2024. Silicon… Read More
Neuroscientists have unveiled their most comprehensive and detailed map of cell types across the entire mouse brain, delivering the latest results of a six-year-long scientific effort in which Seattle’s Allen… Read More
Pfizer’s plan to acquire Seagen for $43 billion has cleared the necessary regulatory hurdles, the pharma titan announced Tuesday. The deal will close on Thursday. Seagen is the largest biotech… Read More
Seattle-based Icosavax, a spin-out from the University of Washington’s Institute for Protein Design, will be acquired by biotech giant AstraZeneca for up to $1.1 billion. The pending acquisition, announced Tuesday, values… Read More
The Allen Institute, the Chan Zuckerberg Initiative and the University of Washington have launched a collaboration called the Seattle Hub for Synthetic Biology, with the goal of using genetically modified… Read More
Valant Medical Solutions, a Seattle startup that develops software to help behavioral health practitioners manage billing and electronic medical records at their offices, has been sold to Resurgens Technology Partners, a private… Read More
Some of the biggest names in longevity research — and at least one Seattle biotech startup — say they’ll enter a $101 million, seven-year competition to turn back the clock… Read More
Shares of Seattle-based publicly traded biotech company NanoString Technologies fell nearly 50% to an all-time low on Monday following its loss in a patent infringement case against 10x Genomics. A… Read More
With revenues declining and net losses increasing, Seattle-based Adaptive Biotechnologies on Thursday said it hired Goldman Sachs to help conduct a review of strategic alternatives for its Minimal Residual Disease… Read More
The Paul G. Allen Frontiers Group, a division of the Seattle-based Allen Institute, is launching a research center in New York to focus on interactions between the nervous system and… Read More
AdaptX, a Seattle tech company that uses AI to help healthcare providers analyze medical data to improve patient care, raised an additional $10 million to support its growth and further… Read More
A group of 20 early-stage life sciences startups in Washington each received $25,000 grants, part of an effort to fuel the “next generation” of life science innovation in the state.… Read More
Phenome Health, a Seattle research organization dedicated to what it calls a data-driven approach to human health and longevity, launched a partnership Wednesday with the Buck Institute for Research on… Read More
First Lady Jill Biden visited Fred Hutchinson Cancer Center on Friday in Seattle, where she met with researchers and spoke about cancer prevention and the need to mitigate side effects… Read More
Italian-born neuroscientist Vittorio Gallo first got interested in research through his appreciation of art, which made him wonder how our brains process colors, forms and compositions. That curiosity launched Gallo… Read More
A Seattle-area tech company has reason to smile after receiving clearance from the Food and Drug Administration for its tooth-tapping device and machine learning platform that helps dental professionals detect… Read More
Plenty of high school students plan to make careers out of coding when they graduate from college. And plenty of other students are probably planning careers as cancer-research scientists. But… Read More
Twenty years after Microsoft co-founder Paul Allen created the bioscience research center that bears his name, Seattle’s Allen Institute is still pushing out into new frontiers. But this weekend, the… Read More
Notch Therapeutics announced that it will shut down its lab in Vancouver, B.C., and lay off about 25 employees, with some offered relocation options. Editor’s note: Story updated with more details… Read More
Seattle-area health tech startup Viome Life Sciences closed a $86.5 million Series C round and announced a deal with CVS to sell its gut microbiome test in 200 CVS locations… Read More
Cocrystal Pharma, a Seattle-area company co-founded by a Nobel Prize winner and backed by biotech veterans, is taking aim at high-profile viruses. The publicly traded company has the green light… Read More
Seattle startup Phase Genomics will develop its platform to detect chromosomal aberrations in cancer with $2.5 million in new funding. The project is fueled with a $2 million small business… Read More
The Access to Advanced Health Institute will develop an RNA vaccine against the chikungunya virus with a fresh $18 million award from the U.S. National Institutes of Health. Chikungunya is… Read More
A new science cluster is growing in Seattle. The two 15-story towers of Dexter Yard, with 528,000 square feet of office and lab space, are starting to fill up with… Read More
Amazon announced Tuesday that it is expanding its Amazon Clinic virtual health care service to all 50 states and Washington, D.C., to help more customers get treatment for a variety… Read More
Seattle startup Proprio raised a $43 million Series B round following FDA clearance for its surgical navigation platform that allows clinicians to see key structures on a screen in three… Read More
After announcing in March that it was seeking “strategic alternatives” for its future, Seattle publicly-traded biotechnology company Neoleukin Therapeutics is now planning to merge with New York City-based Neurogene, a… Read More
CurvaFix, a Seattle-area startup that makes implants to repair fractures in curved bones, raised $39 million. The six-year old company’s flagship product is an implant to repair pelvic fractures. The… Read More
